Immediate Impact
4 from Science/Nature 54 standout
Citing Papers
Pancreatic cancer
2025 Standout
Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
2024 Standout
Works of Suman Redhu being referenced
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)
2015
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Suman Redhu | 649 | 463 | 620 | 10 | 1.1k | |
| Vesna Šneller | 578 | 573 | 357 | 12 | 982 | |
| Angel H. Bair | 544 | 684 | 425 | 17 | 995 | |
| J. W. Chapman | 449 | 174 | 904 | 15 | 1.4k | |
| Ion Cotarla | 367 | 323 | 534 | 19 | 1.0k | |
| A. Shaw | 372 | 762 | 612 | 17 | 1.1k | |
| Yongchang Shi | 566 | 436 | 530 | 9 | 1.3k | |
| Lynda Grinsted | 690 | 712 | 831 | 19 | 1.4k | |
| Jakub Żołnierek | 602 | 762 | 425 | 23 | 1.1k | |
| Heidi Steinfeldt | 687 | 393 | 580 | 10 | 1.1k | |
| Tatyana A. Grushko | 659 | 261 | 650 | 22 | 1.3k |
All Works
Loading papers...